Inactive Instrument

Hospira, Inc. Share Price

Stocks

US4410601003

Pharmaceuticals

End-of-day quote NYSE
- ^USD	-

04/15/04	Hospira : Pfizer wins EU approval for $15 billion Hospira buy	RE
28/15/28	Allergan : Mylan independence from Teva's embrace comes with a price	RE

Latest news: Hospira, Inc.

04/15/04	Hospira : Pfizer wins EU approval for $15 billion Hospira buy	RE
28/15/28	Allergan : Mylan independence from Teva's embrace comes with a price	RE
14/15/14	Hospira : Pfizer offers concessions in bid to win EU okay for Hospira deal	RE
03/15/03	Celltrion : Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount	RE
07/15/07	Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal	RE
14/15/14	AbbVie : Banks see talent flee amid healthcare M&A boom	RE
09/15/09	Actavis : Generic drugmaker Mylan offers $29 billion for Perrigo	RE
05/15/05	AbbVie : boosts cancer drug pipeline with $21 billion Pharmacyclics deal	RE
05/15/05	AbbVie : Biotech buys get pharma M&A off to flying start in 2015	RE
05/15/05	AbbVie : boosts cancer drug pipeline with $21 billion Pharmacyclics deal	RE
25/15/25	Celltrion : Biosimilar copies of blockbuster drug launch in major EU markets	RE
06/15/06	Pfizer : to buy Hospira for $15 billion to bolster hospital products	RE
06/15/06	Hospira : Pfizer's Hospira deal bets on price spike for specialty generics	RE

Press Releases: Hospira, Inc.

27/15/27	Hospira : Announces First Installation of Plum 360™ Infusion System With Hospira MedNet™	PU
27/15/27	Hospira : Announces First Installation of Plum 360(TM) Infusion System With Hospira MedNet(TM)	PR
21/15/21	Hospira : Expert committee BACKS Hospira’s InflectraTM	PU
20/15/20	Hospira : Charleston Area Medical Center Integrates Smart Pump Technology to Advance Patient Safety	PR
20/15/20	Hospira : TGA Approves First mAb Biosimilar	PR

More press releases

News in other languages: Hospira, Inc.

28/15/28	Activision Blizzard et United Continental intègrent le S&P-500
24/15/24	Apple : Les valeurs à suivre à Wall Street
24/15/24	USA-Les valeurs à suivre à Wall Street
03/15/03	American : Les valeurs à suivre sur les marchés américains
03/15/03	USA-Les valeurs à suivre à Wall Street

Generic Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	SUN PHARMACEUTICAL INDUSTRIES LTD.	+0.12%	+0.81%	+13.81%	+64.78%	4.64TCr
	OTSUKA HOLDINGS CO., LTD.	+1.09%	+0.36%	+39.50%	+107.67%	3.73TCr
	ZYDUS LIFESCIENCES LIMITED	+2.00%	+3.78%	+18.12%	+99.54%	1.25TCr
	CIPLA LIMITED	+0.05%	+0.37%	-7.29%	+18.68%	1.18TCr
	KRKA, D. D.	0.00%	0.00%	+18.72%	+139.63%	897.09Cr
	GEDEON RICHTER	-1.34%	-2.73%	+27.67%	+37.52%	709.04Cr
	GLENMARK PHARMACEUTICALS LIMITED	-2.07%	-2.75%	+17.20%	+202.97%	700.76Cr
	ONO PHARMACEUTICAL CO., LTD.	+1.43%	+2.22%	+43.10%	-14.21%	729.19Cr
	SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-2.45%	-0.59%	-51.49%	+4.53%	498.93Cr
	Average	-0.13%	+0.16%	+13.26%	+73.46%	1.59TCr
	Weighted average by Cap.	+0.32%	+0.54%	+19.51%	+79.15%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

As early as today, start finding the best investment opportunities!